407 related articles for article (PubMed ID: 37492224)
41. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
42. Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment.
Koury J; Zhong L; Hao J
Stem Cells Int; 2017; 2017():2925869. PubMed ID: 28356914
[TBL] [Abstract][Full Text] [Related]
43. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
[TBL] [Abstract][Full Text] [Related]
44. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
45. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.
Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H
Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510
[TBL] [Abstract][Full Text] [Related]
46. Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors.
Roca MS; Di Gennaro E; Budillon A
J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31247937
[TBL] [Abstract][Full Text] [Related]
47. Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers.
Mudra SE; Sadhukhan P; Ugurlu MT; Alam S; Hoque MO
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680249
[TBL] [Abstract][Full Text] [Related]
48. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
[TBL] [Abstract][Full Text] [Related]
49. GALNT1-Mediated Glycosylation and Activation of Sonic Hedgehog Signaling Maintains the Self-Renewal and Tumor-Initiating Capacity of Bladder Cancer Stem Cells.
Li C; Du Y; Yang Z; He L; Wang Y; Hao L; Ding M; Yan R; Wang J; Fan Z
Cancer Res; 2016 Mar; 76(5):1273-83. PubMed ID: 26676748
[TBL] [Abstract][Full Text] [Related]
50. The role of microRNAs in breast cancer stem cells.
Schwarzenbacher D; Balic M; Pichler M
Int J Mol Sci; 2013 Jul; 14(7):14712-23. PubMed ID: 23860207
[TBL] [Abstract][Full Text] [Related]
51. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cells metastasis, proliferation, and self-renewal by targeting E-cadherin.
Tang T; Yang Z; Zhu Q; Wu Y; Sun K; Alahdal M; Zhang Y; Xing Y; Shen Y; Xia T; Xi T; Pan Y; Jin L
FASEB J; 2018 Sep; ():fj201801013R. PubMed ID: 30188754
[TBL] [Abstract][Full Text] [Related]
52. Eliminating Cancer Stem-Like Cells in Oral Cancer by Targeting Elementary Signaling Pathways.
Joshi J; Patel H; Bhavnagari H; Tarapara B; Pandit A; Shah F
Crit Rev Oncog; 2022; 27(4):65-82. PubMed ID: 37199303
[TBL] [Abstract][Full Text] [Related]
53. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling.
Ruiz-Torres SJ; Benight NM; Karns RA; Lower EE; Guan JL; Waltz SE
Oncotarget; 2017 Aug; 8(35):58918-58933. PubMed ID: 28938607
[TBL] [Abstract][Full Text] [Related]
54. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract][Full Text] [Related]
55. Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells.
Silva VR; Santos LS; Dias RB; Quadros CA; Bezerra DP
Cancer Commun (Lond); 2021 Dec; 41(12):1275-1313. PubMed ID: 34791817
[TBL] [Abstract][Full Text] [Related]
56. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
[TBL] [Abstract][Full Text] [Related]
57. Targeting Breast Cancer Stem Cells.
Zhang L; Chen W; Liu S; Chen C
Int J Biol Sci; 2023; 19(2):552-570. PubMed ID: 36632469
[TBL] [Abstract][Full Text] [Related]
58. Targeting Developmental Pathways: The Achilles Heel of Cancer?
Dempke WCM; Fenchel K; Uciechowski P; Chevassut T
Oncology; 2017; 93(4):213-223. PubMed ID: 28738360
[TBL] [Abstract][Full Text] [Related]
59. Natural products targeting cancer stem cells: Implications for cancer chemoprevention and therapeutics.
Gairola K; Gururani S; Bahuguna A; Garia V; Pujari R; Dubey SK
J Food Biochem; 2021 Jul; 45(7):e13772. PubMed ID: 34028051
[TBL] [Abstract][Full Text] [Related]
60. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D; Barraco N; Listì A; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
